Novo Ventures is one of the most active life science venture capital investors in the world. So far, we have invested USD 800 million in more than 80 companies and successfully exited over 30 companies through trade sales and IPOs. We proudly share our positive track record with the talented scientists and inspired entrepreneurs who convert our capital and commercial support into revolutionising products and technologies. Together, we’re improving the lives of thousands of people around the world.